Phosphorylated ERalpha, HIF-1alpha, and MAPK signaling as predictors of primary endocrine treatment response and resistance in patients with breast cancer (Q40020433)

From Wikidata
Jump to navigation Jump to search
scientific article published on 8 December 2008
edit
Language Label Description Also known as
English
Phosphorylated ERalpha, HIF-1alpha, and MAPK signaling as predictors of primary endocrine treatment response and resistance in patients with breast cancer
scientific article published on 8 December 2008

    Statements

    Phosphorylated ERalpha, HIF-1alpha, and MAPK signaling as predictors of primary endocrine treatment response and resistance in patients with breast cancer (English)
    Daniele Generali
    Maria P Brizzi
    Leticia Campo
    Giovanni Allevi
    Mauro Papotti
    8 December 2008
    227-234

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit